company background image
688389 logo

Shenzhen Lifotronic Technology SHSE:688389 Stock Report

Last Price

CN¥14.40

Market Cap

CN¥6.2b

7D

-7.4%

1Y

-28.6%

Updated

16 Aug, 2024

Data

Company Financials +

Shenzhen Lifotronic Technology Co., Ltd.

SHSE:688389 Stock Report

Market Cap: CN¥6.2b

688389 Stock Overview

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389 fundamental analysis
Snowflake Score
Valuation6/6
Future Growth6/6
Past Performance5/6
Financial Health5/6
Dividends3/6

Shenzhen Lifotronic Technology Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shenzhen Lifotronic Technology
Historical stock prices
Current Share PriceCN¥14.40
52 Week HighCN¥25.00
52 Week LowCN¥14.00
Beta0.36
11 Month Change-8.75%
3 Month Change-30.27%
1 Year Change-28.64%
33 Year Change-33.79%
5 Year Changen/a
Change since IPO-26.64%

Recent News & Updates

Shenzhen Lifotronic Technology (SHSE:688389) Is Experiencing Growth In Returns On Capital

Aug 16
Shenzhen Lifotronic Technology (SHSE:688389) Is Experiencing Growth In Returns On Capital

Is Shenzhen Lifotronic Technology Co., Ltd. (SHSE:688389) Trading At A 47% Discount?

Jul 25
Is Shenzhen Lifotronic Technology Co., Ltd. (SHSE:688389) Trading At A 47% Discount?

Why Investors Shouldn't Be Surprised By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Low P/E

May 24
Why Investors Shouldn't Be Surprised By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Low P/E

Recent updates

Shenzhen Lifotronic Technology (SHSE:688389) Is Experiencing Growth In Returns On Capital

Aug 16
Shenzhen Lifotronic Technology (SHSE:688389) Is Experiencing Growth In Returns On Capital

Is Shenzhen Lifotronic Technology Co., Ltd. (SHSE:688389) Trading At A 47% Discount?

Jul 25
Is Shenzhen Lifotronic Technology Co., Ltd. (SHSE:688389) Trading At A 47% Discount?

Why Investors Shouldn't Be Surprised By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Low P/E

May 24
Why Investors Shouldn't Be Surprised By Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Low P/E

Shenzhen Lifotronic Technology (SHSE:688389) Might Have The Makings Of A Multi-Bagger

Apr 17
Shenzhen Lifotronic Technology (SHSE:688389) Might Have The Makings Of A Multi-Bagger

Shareholder Returns

688389CN Medical EquipmentCN Market
7D-7.4%-2.4%-0.6%
1Y-28.6%-16.2%-19.0%

Return vs Industry: 688389 underperformed the CN Medical Equipment industry which returned -16.2% over the past year.

Return vs Market: 688389 underperformed the CN Market which returned -19% over the past year.

Price Volatility

Is 688389's price volatile compared to industry and market?
688389 volatility
688389 Average Weekly Movement5.2%
Medical Equipment Industry Average Movement5.1%
Market Average Movement5.6%
10% most volatile stocks in CN Market8.9%
10% least volatile stocks in CN Market3.7%

Stable Share Price: 688389's share price has been volatile over the past 3 months.

Volatility Over Time: 688389's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20081,481Ming Long Huwww.lifotronic.com

Shenzhen Lifotronic Technology Co., Ltd. research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China. The company offers IVD products, such as HPLC, ECLIA, and hematology system; rapid test, molecular and POCT diagnostics. It also offers therapeutic products comprising respiratory and ICU, and wound care; electromagnetic and pneumatic shockwave products.

Shenzhen Lifotronic Technology Co., Ltd. Fundamentals Summary

How do Shenzhen Lifotronic Technology's earnings and revenue compare to its market cap?
688389 fundamental statistics
Market capCN¥6.24b
Earnings (TTM)CN¥347.69m
Revenue (TTM)CN¥1.17b

17.7x

P/E Ratio

5.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688389 income statement (TTM)
RevenueCN¥1.17b
Cost of RevenueCN¥410.16m
Gross ProfitCN¥763.50m
Other ExpensesCN¥415.81m
EarningsCN¥347.69m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 28, 2024

Earnings per share (EPS)0.81
Gross Margin65.05%
Net Profit Margin29.62%
Debt/Equity Ratio11.2%

How did 688389 perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

35%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.